arginine vasopressin has been researched along with Abdominal Obesity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bankir, L; Bouby, N; Enhörning, S; Hedblad, B; Melander, O; Morgenthaler, NG; Nilsson, PM; Persson, M; Struck, J | 1 |
1 other study(ies) available for arginine vasopressin and Abdominal Obesity
Article | Year |
---|---|
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
Topics: Age Distribution; Age of Onset; Aged; Aged, 80 and over; Albuminuria; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycopeptides; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Neoplasms; Obesity, Abdominal; Predictive Value of Tests; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Sweden; Time Factors | 2013 |